From numerous studies, it is known about the role of SGLT-2 inhibitors in reducing glycemia, cardio- and nephroprotection in patients with type 2 diabetes. SGLT-type 1 has been studied somewhat less, the management and activity of which may also be the key to compensating for type 2 diabetes, chronic diseases of the heart, kidneys and other organs and tissues. At the moment, inhibition of SGLT-1 in humans can only be achieved by using combined inhibitors of SGLT-1 /SGLT-2. Drugs with selective inhibition of SGLT-1 are actively studied in animals and in vitro studies. This review is devoted to the principles of the action of sodium-glucose cotransporter type 1, the effect of inhibition of SGLT-1 on pathological conditions, and also evaluated the prospects for the use of iSGLT-1 in humans.
| Mualliflar | Рахимова Гульнара Нишановна, Иброхимов Худойберди Хусанжон угли |
|---|---|
| Jurnal | Марказий Осиё эндокринологик журнали |
| Nashriyot | Республика ихтисослаштирилган эндокринология илмий-амалий тиббиёт маркази |
| ISSN | 2181-3426 |
| Nashr sanasi | 2025-01-24 |
| Jild | 4 |
| Son | 3 |
| Til | Ingliz |
| Ilmiy soha | Tibbiyot |
| Indeksga qo‘shilgan | 2026-09-06 |
: ингибиторы натрий-глюкозного транспортера 1 типа, ингибиторы натрий глюкозного ко-транспортера 2 типа, сахарный диабет 2 типа, канаглифлозин, сотаглифлозин, мизаглифлозин, type 1 sodium-glucose transporter inhibitors, type 2 sodium glucose transporter inhibitors, type 2 diabetes mellitus, canagliflozin, sotagliflozin, misagliflozin, натрий-глюкоза ко-транспортери 1 тип ингибиторлари, натрий-глюкоза ко-транспортери 2 тип ингибиторлари, қандли диабет 2 тип, канаглифлозин, сотаглифлозин, мизаглифлозин
| APA | Рахимова Гульнара Нишановна, & Иброхимов Худойберди Хусанжон угли (2025). WHAT IS KNOWN ABOUT THE TYPE 1 SODIUM-GLUCOSE CO-TRANSPORTER?. Марказий Осиё эндокринологик журнали, 4(3). https://www.tadqiqot.uz/index.php/cae/article/view/10742 |
|---|---|
| GOST (OAK) | Рахимова Гульнара Нишановна, Иброхимов Худойберди Хусанжон угли WHAT IS KNOWN ABOUT THE TYPE 1 SODIUM-GLUCOSE CO-TRANSPORTER? // Марказий Осиё эндокринологик журнали. – 2025. – T. 4, № 3. |
| MLA | Рахимова Гульнара Нишановна, and Иброхимов Худойберди Хусанжон угли. “WHAT IS KNOWN ABOUT THE TYPE 1 SODIUM-GLUCOSE CO-TRANSPORTER?.” Марказий Осиё эндокринологик журнали, 4(3), 2025. https://www.tadqiqot.uz/index.php/cae/article/view/10742 |
| Chicago | Рахимова Гульнара Нишановна, and Иброхимов Худойберди Хусанжон угли. “WHAT IS KNOWN ABOUT THE TYPE 1 SODIUM-GLUCOSE CO-TRANSPORTER?.” Марказий Осиё эндокринологик журнали, 4(3) (2025). https://www.tadqiqot.uz/index.php/cae/article/view/10742 |
| Harvard | Рахимова Гульнара Нишановна, and Иброхимов Худойберди Хусанжон угли (2025) ‘WHAT IS KNOWN ABOUT THE TYPE 1 SODIUM-GLUCOSE CO-TRANSPORTER?’, Марказий Осиё эндокринологик журнали, 4(3). https://www.tadqiqot.uz/index.php/cae/article/view/10742 |
| BibTeX | @article{article2025,
title = {WHAT IS KNOWN ABOUT THE TYPE 1 SODIUM-GLUCOSE CO-TRANSPORTER?},
author = {Рахимова Гульнара Нишановна and Иброхимов Худойберди Хусанжон угли},
journal = {Марказий Осиё эндокринологик журнали},
year = {2025},
volume = {4},
number = {3},
url = {https://www.tadqiqot.uz/index.php/cae/article/view/10742}
} |
Boshqa maqola uchun iqtibos tayyorlash
Relevance: Obesity is a significant global health issue requiring effective treatment methods. This study evaluates the impact of liraglutide, a glucagon-like peptide-1 (GLP-1) agonist, on non-diabetic obese patients…
Background. Ultrasound-based thyroid nodule risk stratification, such as TIRADS, was introduced to reduce intervention in the “global epidemic” of “overdiagnosis” of thyroid cancer. Methodology for revealing the…
Objective. Obesity has become a global epidemic, affecting more than 600 million people worldwide. WHO reports that in 2022, 2.5 billion adults (18 years and older) were overweight. Of these, 890 million were living…
Relevance. Graves' disease (GD) is a hereditary organ-specific autoimmune disorder. The incidence of GD in children has increased by 27.3-30.1% over the last 10-20 years, with a more pronounced rise in the last decade…
Relevance. Type 2 diabetes mellitus (DM2) is a chronic disease that requires gradual intensification of therapy to control glycemia. Studies show that poor control lasts up to seven years, increasing the risk of…
Endocrine ophthalmopathy is an autoimmune disease often associated with thyroid dysfunction. It affects the tissues of the orbit and periorbital structures, causing their edema and degenerative changes. One of the most…
Background. Research shows that excess weight negatively affects the development and progression of respiratory diseases. As the SARS-CoV-2 pandemic continues, it is important to understand how body mass index (BMI)…
Currently, thyroid gland (TG) diseases with nodular formations are widespread, and due to ultrasound examination, it is possible to detect even the smallest nodules. The prevalence rate among the elderly population…
Diabetic retinopathy (DR) is recognised as the leading cause of blindness and low vision among people of working age. Diagnosis and grading of the disease is based on detection and statement, first of all, of vascular…
Purpose: To study the characteristics of diabetes occurring after contracting COVID-19. Methods: Hemostasis parameters, vitamin D levels, and beta cell-specific autoantibodies were tested in 70 patients with…
Марказий Осиё эндокринологик журнали — barcha maqolalar · 2025-yil arxivi
The investigation of the issues related to bone metabolism in individuals with idiopathic stunting is important, as growth disorders in children and adolescents often result in alterations in bone mineral density, which…
Type 2 diabetes mellitus (T2DM) is associated with an increased risk of developing cognitive impairments, including dementia. In recent years, sodium-glucose co-transporter 2 inhibitors (SGLT2i) have gained popularity…
Diabetes-related peripheral neuropathy is a common and debilitating complication of diabetes, contributing significantly to morbidity and healthcare costs. Our systematic review aims to determine the prevalence of BPDN…
Children with type 1 diabetes (T1D) are at an increased risk of developing kidney disease, with a significant proportion of cases emerging in the early stages of the disease. Up to 65% of children at the onset of T1D…
Background. Research shows that excess weight negatively affects the development and progression of respiratory diseases. As the SARS-CoV-2 pandemic continues, it is important to understand how body mass index (BMI)…
Настоящее исследование посвящено разработке алгоритма раннего выявления сенсоневральной тугоухости у детей с использованием методов полимеразной цепной реакции (ПЦР). Обследовано 235 детей с нарушениями слуха, из…
В статье представлены клинические аспекты и диагностические проблемы выявления сенсоневральной тугоухости у новорождённых с перинатальной патологией. Обследовано 115 новорождённых, из которых 35 перенесли асфиксию, а у…
Сенсоневральная тугоухость (СНТ) у детей остаётся одной из наиболее актуальных проблем современной оториноларингологии и медицинской генетики. Ранняя диагностика нарушений слуха играет ключевую роль в предупреждении…
Сенсоневральная тугоухость у новорождённых является одной из ведущих причин нарушения слухоречевого развития и ранней инвалидизации. Наиболее уязвимыми считаются дети, перенёсшие перинатальные осложнения, такие как…
Mazkur eksperimental tadqiqotda yuqori yog‘li ratsion va seftriaksonning lipid hamda uglevod almashinuviga alohida va birgalikdagi ta’siri 160 ta oq zotsiz erkak kalamushda o‘rganildi. Tajriba hayvonlari to‘rtta guruhga…
Мазкур тадқиқотда Тошкет вилоятидаги Ўрта Чирчиқ тумани 25-сонли, Бўка тумани 3-сонли ва 9-сонли давлат мактабгача таълим ташкилотларида 2025 йил ёз мавсумидаги таомномаларнинг озиқ-овқат маҳсулотлари билан…